Location History:
- Saitama, JP (2005)
- Chuo-ku, JP (2013)
Company Filing History:
Years Active: 2005-2013
Title: The Innovations of Shin-ya Ohnuma
Introduction
Shin-ya Ohnuma is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors related to various health conditions. With a total of 2 patents to his name, his work continues to impact the medical community.
Latest Patents
Ohnuma's latest patents include innovative arylamidrazone derivatives that exhibit antagonistic action against S1P receptors. These compounds are represented by a specific formula and include pharmaceutically acceptable salts. Additionally, he has developed halogenobenzylaminopropionic acid derivatives, which are also represented by a specific formula. These derivatives serve as active ingredients in drugs aimed at treating diabetes, hyperlipidemia, and similar pathological conditions.
Career Highlights
Throughout his career, Shin-ya Ohnuma has been associated with Toa Eiyo Ltd., a company known for its commitment to advancing pharmaceutical research and development. His work has been instrumental in creating new therapeutic options for patients suffering from various diseases.
Collaborations
Ohnuma has collaborated with esteemed colleagues, including Takeshi Hasegawa and Tomoyuki Sada. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Shin-ya Ohnuma's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving health outcomes. His innovative work continues to pave the way for new treatments and advancements in medical science.